Skip to main content

Vanesa Richarte Fernández

-

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Vanesa Richarte Fernández

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

-

Graduate in Medicine and Surgery from the Universitat Autònoma de Barcelona. Specialist in Psychiatry at the Hospital de la Santa Creu i Sant Pau. PhD in Psychiatry and Clinical Psychology from the Universitat Autònoma de Barcelona (UAB). Master's Degree in Paidopsychiatry (UAB).

Coordinator of the ADHD Programme at Vall de Hebron University Hospital. Associate clinical lecturer at the Universitat Autònoma de Barcelona.
My healthcare work is focused on the assessment, diagnosis and treatment of ADHD and its comorbidities in children, adolescents and adults.

Co-author of more than 50 national and international publications on ADHD, with an h=25 index and 5 book chapters. Member of the Vall Hebron Research Institute, research focused on childhood, adolescent and adult ADHD, including clinical trials on pharmacological and psychological treatments, neuroimaging, genetics and intestinal microbiome studies.

Projects

Identificación de factores genéticos de riesgo en el TDAH a través del estudio del perfil de expresión a escala genómica en linfocitos mediante análisis de microarrays y estudios de asociación de tipo poblacional

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 152900.44
Reference: PI11/00571
Duration: 01/01/2012 - 30/04/2016

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)

IP: José Antonio Ramos Quiroga
Collaborators: Núria Gómez Barros, Mercedes Palomar Martínez, Vanesa Richarte Fernández
Funding agency: EUROPEAN COMMISSION
Funding: 31250
Reference: ADDUCE_FP7HEALTH2010
Duration: 09/12/2013 - 31/08/2017

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.